Are drug-eluting stents safe in the long term?

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 2, 2009, Pages 154-155

  Généreux, Philippe ^a   Mehran, Roxana ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ANGIOPLASTY; BARE METAL STENT; COMORBIDITY; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; REVASCULARIZATION; RISK; SAFETY; STABLE ANGINA PECTORIS; STENT THROMBOSIS;

EID: 58849111855     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081907     Document Type: Note

References (11)

1. Lagerqvist B, James SK, Stenestrand U, et al.; SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-19.
2. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78.
3. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
4. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9.
5. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-9.
6. Philpott AC, Southern DA, Clement FM, et al; the APPROACH Investigators. Long-term outcomes of patients receiving drug-eluting stents. CMAJ 2009;180:167-74.
7. Tu JV, Bowen J, Chiu M, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007;357:1393-402.
8. Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008;359:1330-42.
9. Kirtane AJ, Gupta A, Iyengar S, et al. Drug-eluting stent versus bare-metal stent use: meta-analysis of randomized trials and observational studies. Circulation 2008;118(S):1040.
10. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-48.
11. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.